ORIC

Oric Pharmaceuticals (ORIC)

About Oric Pharmaceuticals (ORIC)

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Details

Daily high

$8.25

Daily low

$7.44

Price at open

$7.52

52 Week High

$16.65

52 Week Low

$6.33

Market cap

579.4M

Dividend yield

0.00%

Volume

690,836

Avg. volume

334,129

P/E ratio

-4.54

Oric Pharmaceuticals News